Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The Laboratory of Malaria Immunology and Vaccinology (LMIV) aims to conduct the research relevant to malaria immunology and vaccine development, to pursue novel vaccine concepts, to produce prototype malaria vaccines, and to conduct early-phase clinical trials of promising vaccine candidates. Major research areas include enhancing the basic understanding of malaria pathogenesis and immunity in humans, developing strategies for anti-infection, anti-disease, and transmission-blocking vaccines, production and formulating the antigens suitable for human testing, developing assays and performing animal trials that define the potential for protection, conducting clinical trials to test vaccines in the United States and in malaria endemic areas, establishing scientific collaborations and obtain outside funding to accelerate the program. Together, the discovery sections and Production Unit form a research and testing enterprise that can rapidly translate ideas into proof of concept trials and then capture basic information about human immunity and responses to infection during human clinical trials.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi